Healthtech & Wellness VC Funds

Ivy Ventures is a Carmel, Indiana-based venture capital firm founded in 2022 and launched with a $20 million fund raised from Midwest investors. The firm targets early-stage startups in enterprise software, healthcare IT, and hard technology, with check sizes of $500,000 to $2 million. Co-founded by General Partner Scott Kraege, Mike Reynolds (CEO of Innovatemap), and John Wortman (CEO of Valeo Financial Advisors), Ivy Ventures operates as a founder-led, operator-based fund. Kraege previously co-founded and led Mobi Wireless Management LLC, a software firm with approximately 315 employees that was acquired by Tangoe Inc. in late 2018. The firm distinguishes itself through a smart capital approach in which portfolio companies are vetted, funded, and supported by seasoned operators, investors, and product experts. Corporate partners Innovatemap and Valeo Financial Advisors provide built-in portfolio support for market research, product design, branding, and financial advisory services. The fund has recruited a curated advisory team with vertical industry expertise alongside horizontal capabilities in product, finance, and operations. The initial portfolio includes three companies: Mobile ReCell Inc. in Fishers, Indiana, focused on IT asset tracking and recovery; Learnexus in New York City, an e-learning platform; and Native AI in New York City and Cincinnati, a generative AI market intelligence platform that raised $3.5 million to create digital customer clones. Ivy Ventures focuses on identifying high-potential founders across the Midwest and beyond, with its operator-led model providing portfolio companies with practical guidance on company building at the stage where capital alone is insufficient. The fund's founding team brings direct experience scaling software businesses to acquisition, which informs its selection and support of early-stage founders in similar trajectories.

IvyCap Ventures is one of India's leading homegrown venture capital funds, founded in 2011 and headquartered in Mumbai with additional offices in Delhi, Bengaluru, the United States, and Singapore. The firm leverages the IIT and IIM alumni ecosystems to power the Indian startup landscape. Founded by Vikram Gupta (IIT Delhi and Case Western Reserve MBA) and Ashish Wadhwani, IvyCap manages assets of over $650 million (INR 6,000 crore) and has invested in more than 65 companies. The firm closed Fund III in 2024 at INR 2,100 crore (approximately $250 million), targeting 25 or more startups with initial checks of INR 30 to 50 crore ($3.6 to $6 million) per company. The team of 53 includes 20 partners. The firm leads rounds across seed to Series B, and is sector-agnostic in its pursuit of startups with differentiated business models and strong unit economics. IvyCap is India's first homegrown VC to create a dragon company: Purplle.com became a unicorn in 2022, generating a partial exit at 22X returns. BlueStone, a jewelry platform, is IPO-bound. Other portfolio companies include Snitch in fashion, Miko in social robotics, TurboHire in recruitment AI, Dhruva Space in space technology, Raana Semiconductors, Eggoz Nutrition, and M.O.M in personal care. The most recent investment was in DATOMS in February 2026. The portfolio spans consumer technology, deep tech including SaaS, AI and machine learning, semiconductors, cybersecurity, and IoT, as well as fintech, edtech, agritech, and electric vehicles. IvyCap created India's first Endowment Fund at IIT Delhi, launched by the President of India in October 2019, directing a portion of fund manager profits back to IITs and IIMs. The firm operates THRIVE, a structured portfolio value creation platform with more than 100 mentors drawn from its alumni networks. IvyCap has more than 25 institutional investors across its funds and has established itself as a defining institution in the Indian venture ecosystem through its alumni-network sourcing model and its record of backing companies from seed through to public markets.

J-Ventures is a community-driven global venture capital fund based in Palo Alto, California, founded in 2015 by Oded Hermoni. Operating under the banner of a 'Capitalist Kibbutz,' the J-Ventures Group — comprising J-Ventures Funds, J-Impact, and J-Angels — collectively manages $100 million in assets, with the core fund exceeding $60 million. The firm invests across enterprise software, fintech, cybersecurity, proptech, aviation, gaming, clean technology, agtech, and healthcare, deploying initial checks of $250K to $1 million with follow-on reserves. J-Ventures focuses on US-Israel cross-border opportunities and was the most active foreign VC in Israel in the first half of 2024. The fund has backed 42 active portfolio companies with 6 acquisitions to date. Notable holdings include Descope, Beehero (agtech), Finout (cloud cost management), DataRobot (AI platform), Bria.ai (generative AI), Hidden Level (airspace security), VisbyMedical (rapid diagnostics), and Cents (laundry technology). Exits include Omada Health, which went public in 2025, alongside Conversa Health, Concertio, MachEye, and Ananda. Hermoni has personally invested in more than 70 companies since 2005, with five reaching unicorn status. What distinguishes J-Ventures is its LP structure: the fund is backed by 470 expert members, including 140 serial founders, more than 100 current and former GPs from leading VC firms, and 170 Fortune 500 executives. This community — augmented by a 180-member J-Advisory network of former startup founders, CXOs, and industry executives — provides portfolio companies with operational guidance and market access that extends well beyond capital. The firm provides hands-on support through every stage of a company's growth.

J.F. Shea Ventures (Shea Ventures) is the corporate venture capital division of J.F. Shea Co., Inc., a family-owned company with origins tracing to 1881, when John Francis Shea founded the business in Portland, Oregon. The venture arm was established in 1968, making it one of the oldest corporate venture capital programs in the United States. Based in Walnut, California, Shea Ventures stewards the Shea family's wealth generated through its parent company's construction, homebuilding through Shea Homes, commercial real estate through Shea Properties, and heavy construction businesses. Managing Director John C. Morrissey leads a team of five. The venture division has invested in 161 companies across 9 funds, with 52 exits, and remains a SEC-registered investment adviser. Shea Ventures helped make the technology revolution a reality through early investments in companies that grew into industry leaders, including Compaq Computer Corporation, Altera Corp, Brocade Corp, and Exodus Corp. Today the firm invests at seed, early, and later stages in software including web marketplaces and SaaS platforms, semiconductors, biotechnology, and medical devices, with checks typically in the $1 million to $10 million range. Investments span Silicon Valley through to the eastern United States. The most recent investment was in Sorcero, an AI-powered life sciences content intelligence company, at Series B in October 2025. The most recent exit was NEXT Trucking, a digital freight marketplace, in February 2024. Shea Ventures operates with the patient capital orientation typical of a family office, maintaining positions across long investment cycles without the fund-life pressures that constrain institutional vehicles. This structure allows the firm to support portfolio companies through multiple rounds and market cycles, and has enabled a consistent track record of backing technology and life sciences companies from early formation through to significant exits over more than five decades.

J&T Ventures is an early-stage venture capital fund founded in 2014 and based in Prague, Czech Republic, managing EUR 40 million and investing in promising startups from the CEE, SEE, Nordics, and Baltics regions. The fund operates from the J&T Banka building in Prague's Karlin district and is structured as an independent VC where the partners have personally invested in the fund's success rather than operating as salaried professionals managing someone else's capital. Managing Partner Adam Kocik leads a team of eight including two partners. The firm leads rounds and deploys EUR 300,000 to EUR 2.5 million per company across pre-seed to Series A stages. J&T Ventures takes a sector-agnostic approach with primary focus areas including fintech, healthcare, education, IoT, smart city, data analytics, AI, cybersecurity, climate technology, gaming, and proptech. Over more than ten years of operation, the firm has invested in approximately 31 companies across seven countries with five successful exits. Notable portfolio companies include Apify, a web scraping platform backed by Y Combinator; Wultra, a digital security company that raised EUR 3 million in January 2025; Born Digital in conversational AI; SprayVision, a precision agriculture company that raised $2 million at seed stage in June 2024; and Daytrip, a city-to-city transfer platform. Exits include Dotykacka, a POS system that completed an IPO; 720 Degrees; Dateio; Scratch Wars; and FetView. The most recent investment was in ValkaAI in February 2026. J&T Ventures averages approximately two new investments annually, reflecting a deliberate pace that allows the partnership to engage deeply with each portfolio company. The fund's partner-as-LP structure aligns incentives with founders, and its decade-long track record across multiple European technology cycles has established it as a consistent seed-stage investor in the Central and Eastern European startup ecosystem.

J12 Ventures is a Stockholm-based venture capital firm founded in 2019, specializing in early-stage investments. The firm focuses on companies developing AI technologies, data infrastructure, and software applications, targeting sectors such as e-commerce, fintech, and delivery services. J12 Ventures operates mainly within the Nordics and Europe but also has a presence in London, Paris, and Helsinki​. Notable investments include companies like Deasie, which provides data governance solutions for enterprises; Unify, which dynamically routes prompts to the most suitable large language model (LLM) providers; and Buddywise, which uses computer vision to prevent workplace fatalities. Other significant portfolio companies are Ayora, offering automated revenue management for professional services, and Inex One, a marketplace for expert insights. J12 Ventures is managed by an international team of former founders and industry experts, providing unique access to resources and insights for their portfolio companies. The firm typically invests in pre-seed and seed stages, with a focus on backing founders who demonstrate exceptional ingenuity and resilience.

Jackson Square Ventures (JSV) is an early-stage venture capital firm founded in 2011 and based in San Francisco, California. The firm manages $245 million in its current fund and has deployed more than $700 million across at least four funds since inception. JSV focuses on seed and Series A investments in software, marketplace, and AI-native companies, with check sizes ranging from $100K to $5 million and a sweet spot around $1.5 million. The founding team — Greg Gretsch, Bob Spinner, and Pete Solvik — are all former founders or senior tech executives; Solvik served as SVP and CIO at Cisco before joining the firm. All partners bring direct operating experience and lead rounds for the companies they back. JSV has backed more than 60 companies across its funds, producing 4 unicorns and 50 portfolio exits. The firm was a principal investor in DocuSign and Upwork, both of which achieved NASDAQ IPOs. Other well-known portfolio companies include Strava, Seismic, and OfferUp. More recent investments include Clarity Pediatrics, where JSV led a December 2025 round, as well as Artera and Tandemn. The latest exit was Alto Pharmacy in March 2025. JSV emphasizes partnering with founders at pivotal early stages, providing not just capital but a network of experienced operators and fellow founders. The firm's partners-as-former-founders ethos shapes every engagement — the team draws on direct experience building and scaling companies to support entrepreneurs through the operational and strategic challenges of early growth. This hands-on orientation has been consistent across the firm's 14-year history.

JAFCO Group Co., Ltd. is the oldest and largest venture capital firm in Japan, established in April 1973 as Japan Associated Finance Co. Ltd with initial capital of 500 million yen. Headquartered in the Toranomon district of Minato-ku, Tokyo, JAFCO is publicly listed on the Tokyo Stock Exchange (8595.T) and maintains regional offices in Chubu, Kansai, and Kyushu. The firm has established over 100 investment funds with total committed capital exceeding 1 trillion yen — approximately $6.8 billion. With 109 professionals across venture capital, buyout, business development, and fund management, JAFCO operates in Japan, Asia, and the United States. The firm leads rounds across its portfolio and invests from pre-founding through later stages. JAFCO has made 4,247 investments resulting in an extraordinary 1,041 IPOs — one of the highest IPO track records of any venture capital firm globally. Investment focus spans business services, software, healthcare, SaaS, manufacturing, life sciences, e-commerce, IoT, AI, and smart cities. Notable portfolio companies include Cyberdyne (maker of the HAL robotic suit), Sansan (business card management software), freee (cloud accounting, IPO exit), and UUUM (YouTube multi-channel network). JAFCO is also launching a new $678 million fund focused on Japanese startups in AI, space, and nuclear fusion. JAFCO's investment philosophy combines deep sector expertise with a long-term partnership approach, built over five decades of backing Japanese entrepreneurs across every market cycle. A former US subsidiary, JAFCO Ventures in Palo Alto, later became independent as Icon Ventures, and JAFCO Asia manages approximately $3 billion in assets with 27 team members — reflecting the firm's sustained commitment to cultivating innovation ecosystems beyond Japan.

JAM Fund, founded by Justin Mateen in 2020 and headquartered in Los Angeles, California, is a venture capital firm known for investing in visionary founders disrupting large markets. The firm focuses on early-stage investments, particularly in sectors such as fintech, e-commerce, SaaS, and consumer technology. JAM Fund has a portfolio of over 100 investments and has achieved notable exits including companies like Bueno Finance, COMPASS Pathways, and Rebate. Some of their recent investments include Rollup, Conta Simples, and Urbanic. JAM Fund often co-invests with other prominent venture capital firms like Y Combinator, Andreessen Horowitz, and Thiel Capital, enhancing their ability to support startups with substantial resources and networks. The firm leverages its founder's extensive network and experience to provide strategic guidance and operational support to its portfolio companies, helping them navigate growth and scale effectively. With a focus on high-potential early-stage companies, JAM Fund continues to make significant contributions to the startup ecosystem.

January Ventures is a forward-thinking venture capital firm committed to investing in early-stage B2B startups that are digitally transforming traditional industries. Co-founded by Maren Bannon and Jennifer Neundorfer, the firm is dedicated to supporting ambitious founders who are often overlooked by traditional VC networks. The fund's notable investments include companies like Clarity Pediatrics, a health tech startup, and Treefera, a data platform for environmental sustainability. January Ventures is known for its strong community of founders, particularly from underrepresented backgrounds, providing not only financial support but also strategic guidance and operational advice. Geographically, January Ventures focuses primarily on the U.S. but has a presence in London, reflecting their global outlook. They emphasize a hands-on approach, frequently leading rounds and staying actively involved with their portfolio companies through various stages of growth. January Ventures' team brings a wealth of experience from diverse backgrounds. Maren Bannon, based in London, has a rich history in marketing and product roles at companies like Genentech and Roche. Jennifer Neundorfer, based in Boston, has a background in media and advertising, having worked at YouTube and 21st Century Fox. Together, they leverage their deep industry knowledge and extensive networks to help startups succeed. The firm prides itself on compassionate collaboration, providing founders with honest feedback and essential resources, from PR strategy to hiring and fundraising. This approach has earned January Ventures a reputation as a highly supportive and impactful investor in the startup ecosystem.

Javelin Venture Partners is a venture capital firm based in San Francisco, established by experienced entrepreneurs. The firm focuses on early-stage investments, primarily in the late seed and early Series A rounds, with initial check sizes ranging from $500K to $4M. Their investment strategy is geared towards software and technology companies with substantial growth potential and innovative business models. Javelin Venture Partners has a diverse portfolio, including companies like MasterClass, Thumbtack, SmartAsset, and Niantic. They seek founders who exhibit relentless grit, are data-driven, and possess exceptional recruiting and fundraising skills. The firm's evaluation criteria emphasize dynamic and capable founders, capital-efficient business models, and large market opportunities. The leadership team includes Managing Directors Jed Katz and Noah J. Doyle. Jed Katz has a rich history in online commerce and has founded multiple companies. He serves on the boards of Thumbtack, SmartAsset, HighArc, and others. Noah J. Doyle has extensive experience in product management and business development, having directed enterprise products at Google Earth and Google Maps. He sits on the boards of Appvance, Armory, Estimote, and others.

Jaza Rift Ventures is an impact investment firm founded in 2022 and based in Nairobi, Kenya, with additional offices in Accra, Ghana, and Luxembourg. Launched in partnership with Villgro Africa, the firm is exclusively focused on healthcare in Africa. The maiden Jaza Rift Pioneers Fund is a $5 million impact VC fund deploying checks of $100K to $500K at pre-seed, seed, and seed-extension stages into healthtech, medtech, and biotech founders across the continent. The firm also targets a larger $50 million fund for early-stage investments in digital health, medtech, and biotech. Jaza Rift leads rounds within its portfolio. The firm is a recognized Beyond The Billion partner. Managing Partner Sewu-Steve Tawia brings more than 20 years of experience in development finance, consulting, angel investing, and venture capital across Europe and Africa. Tawia holds CAIA and CIFE certifications and is an alumnus of London Business School, Audencia Business School, and Stanford GSB. The partnership with Villgro Africa provides access to a pipeline of more than 1,600 startups, with 20 identified as potential fund returners. Portfolio companies include Taneel (life and health insurance), Neopenda (medical devices for emerging markets), Plural Health (enterprise healthcare systems), and YeneHealth (Ethiopian femtech, where Jaza Rift led the pre-seed round in July 2023). Jaza Rift's thesis is straightforward: affordable, accessible, and high-quality healthcare in Africa represents both an urgent social need and a significant investment opportunity. The firm provides the '4Cs' framework alongside a network of advisors spanning biotech, medtech, and digital health to help portfolio founders navigate the unique challenges of building healthcare businesses across African markets.

Jazz Venture Partners, founded in 2015 and based in San Francisco, is a leading venture capital firm focusing on technologies that enhance human performance. They have a diverse portfolio that includes notable companies like Sounding Board, KLOWEN Braces, Robust.AI, AppliedVR, Pymetrics, Embodied, and Mahana Therapeutics. Their investment strategy is centered on early-stage startups, particularly at the pre-seed, seed, and Series A stages, and they focus heavily on sectors like EdTech, HR Tech, software, health and wellness, robotics, and AI/ML. Geographically, Jazz primarily invests in U.S.-based companies but maintains a global perspective. Their approach includes backing innovative companies that leverage cutting-edge neuroscience and digital technologies to push the boundaries of human potential. They have successfully exited several investments, including Akili Interactive, which went public, and Pymetrics, acquired in 2022. Jazz Venture Partners typically writes checks in the range of $500K to $3M and is open to connecting with startups through their extensive network. They build their investment funnel through a combination of proactive scouting and leveraging their robust network in the tech and science communities​.

JCI Ventures is the corporate venture capital arm of Johnson Controls International, a global leader in building technologies and solutions. Founded in 2000 and based in the San Francisco Bay Area — with Johnson Controls headquartered in Milwaukee, Wisconsin — the firm invests in startups that are strategically aligned with JCI's core markets and adjacent opportunities. The investment thesis centers on creating intelligent, energy-efficient, and secure buildings and environments for the next generation of smart cities. Focus areas include AI and machine learning, IoT, blockchain, robotics, security, and smart building technologies. The firm also previously operated as Tyco Ventures following Johnson Controls' 2016 merger with Tyco. JCI Ventures has made 43 investments with 10 exits. The portfolio spans seed through Series B stages with checks typically in the $1 million to $10 million range. Notable holdings include Artisight (an IoT platform for smart hospitals, last invested October 2024), Alcatraz (AI-powered access control), Audette (building decarbonization software), Nozomi Networks (OT/IoT cybersecurity, which raised a $100 million round — Johnson Controls also signed a services framework agreement with the company), and ENVIRO-TEC (HVAC). The most recent exit was Nozomi Networks in September 2025. Portfolio companies gain access to Johnson Controls' global network of resources and its massive installed customer base across commercial and industrial buildings worldwide. This strategic access — to distribution channels, pilot sites, and enterprise customers — is the primary value-add JCI Ventures extends beyond capital. The firm is led by Senior Director Rain Cui.

Jeito Capital is a global private equity fund specializing in life sciences, with a strong focus on biopharma companies. Founded in Paris, Jeito supports breakthrough innovations that address critical unmet medical needs. The fund's mission is centered on improving patient outcomes through targeted investments in early-stage and growth-stage biopharma companies, particularly those working on therapies for life-threatening diseases. Jeito operates with a unique long-term investment strategy, providing continuous financial support from clinical development through to market access. This allows its portfolio companies to achieve significant milestones while accelerating drug development. The fund has a diverse portfolio of companies, including SparingVision, which is developing gene therapy treatments for inherited retinal diseases, and CatalYm, a biopharma firm working on novel cancer immunotherapies. With over €534 million under management, Jeito's integrated team of experts spans the entire drug development value chain, offering portfolio companies not only capital but also strategic guidance in areas like regulatory affairs, clinical trials, and commercialization. Jeito’s investment approach is also distinguished by its emphasis on global impact, working across Europe and the United States to bring life-saving treatments to market. Jeito has rapidly become a significant player in the life sciences sector, driven by its patient-centered philosophy and focus on fostering the growth of biotech companies that are on the cutting edge of medical innovation.

Jerusalem Venture Partners (JVP), founded in 1993 by Dr. Erel Margalit, is a leading international venture capital firm headquartered in Jerusalem, with additional offices in New York, Tel Aviv, and Be’er Sheva. The firm focuses on early to growth-stage investments across various sectors including cybersecurity, big data, fintech, foodtech, and digital health. Notable investments by JVP include CyberArk, QlikTech, and Earnix. CyberArk is renowned for its cybersecurity solutions and went public on NASDAQ. QlikTech, a cloud-based business intelligence platform, also had a successful NASDAQ IPO. Earnix, which provides AI-based analytics solutions for insurers and banks, achieved unicorn status with its significant valuation. JVP has raised over $1.4 billion across multiple funds and has a strong track record of successful exits. The firm supports its portfolio companies through the Margalit Startup City model, which offers office space, management support, and strategic guidance in dynamic creative campuses located in Jerusalem and New York. These centers foster innovation and collaboration among startups, entrepreneurs, and strategic partners​.

iangmen Ventures, established in 2015, is an early-stage venture capital firm based in Beijing, China. The firm focuses on investing in tech-driven startups, particularly those in sectors such as artificial intelligence, healthcare, IoT, and enterprise computing. Their strategy revolves around leveraging technological innovation to unlock business value, primarily targeting early-stage companies that show significant growth potential. Jiangmen has invested in over 50 startups across various industries, including notable companies like Hesai Technology and Heisenberg Robotics. The firm is known for its commitment to backing companies involved in frontier technology such as quantum computing, AI-powered platforms, and advanced manufacturing. One of its more recent investments includes MyTwins.ai, a Hangzhou-based AI platform. Co-founded by Vanessa Gao and Qiang Shen, Jiangmen Ventures takes a hands-on approach with portfolio companies, offering not only financial backing but also strategic mentorship to help startups scale effectively. The firm places a strong emphasis on innovative solutions that can disrupt traditional industries and foster industrial upgrades, particularly in China’s rapidly growing tech landscape.

Johnson & Johnson Innovation is a global network dedicated to empowering healthcare innovators. Founded in 2012, JLABS supports early-stage companies in the pharmaceutical, medical device, consumer, and health tech sectors. Their mission is to foster the development of life-saving and life-enhancing health solutions. JLABS operates across multiple locations, including San Diego, San Francisco, Cambridge, Shanghai, and New York. They offer a robust infrastructure and resources to startups, facilitating collaboration and growth. The initiative has made over 400 investments, including notable companies such as Capstan Therapeutics and Synthis Therapeutics, focusing on biotechnology and medical devices. Their investment strategy emphasizes strategic partnerships and co-investments, working alongside various industry leaders and funding bodies to maximize impact. Recent investments include support for companies like Immunyx, Grapheal, and Neurogene, showcasing their commitment to advancing innovative healthcare solutions.

JME Venture Capital, established in 2009, is a prominent venture capital firm based in Madrid, Spain. It focuses on early-stage technology startups, investing primarily in Spanish companies with notable expansions across Europe and occasional investments in the US. The firm has raised three funds with over €120 million in assets under management (AUM), investing between €100k and €3m per deal. JME's investment portfolio includes successful companies like Flywire, Jobandtalent, and Voi. Their investment strategy targets sectors such as fintech, healthtech, and blockchain technology. Notably, JME has invested in over 70 startups, leading to significant exits including companies like Volava and Waynabox. The team at JME Venture Capital is led by Samuel Gil and Javier Alarcó, who emphasize a fast and transparent investment process. They support founders with global-scale resources while allowing them to maintain control over their vision and operations​.

Johnson Venture Partners (JVP) is an Atlanta-based micro venture capital fund founded in 2015 by Matt Johnson. The firm invests $50,000 to $500,000 in seed and early-stage startups throughout the Southeast United States, targeting pre-money valuations under $10 million with potential for 10x or greater returns. JVP operates with an open-ended fund life cycle, allowing patient capital without the artificial time constraints of traditional venture structures. Managing Partner Matt Johnson has invested in more than 40 startups over 15-plus years, serves on the Venture Atlanta selection committee, and is a Founding Partner of Fund That Tiger, a Clemson alumni investment vehicle. General Partner Robert Cramer brings 35 years of experience, including founding A.D.A.M. Inc. (IPO 1995, sold 2010) and co-founding ThePort Network. JVP is industry-agnostic across technology-driven sectors including SaaS, AI, fintech, healthcare, advanced manufacturing, consumer products, and digital media. The portfolio of 41 companies spans a range of stages and verticals, with notable holdings including 6am City (local media), Altis Biosystems (biotech), CareTrack (healthtech), NewSci (AI), Nickl Pay (fintech), Viva Finance (fintech), LimeLoop (sustainable packaging), and Oncore Golf. The most recent investment was RootNote in October 2024. One known exit has been recorded: Miventure in October 2021. JVP targets key Southeast startup ecosystems including Atlanta, Charlotte, Greenville, Nashville, Orlando, Tampa, and Raleigh-Durham. The firm's mission is to create exceptional long-term value for both entrepreneurs and LPs through patient capital, trusted founder relationships, and the operational expertise that the partnership brings from decades of company-building experience.

Jolt Capital is a Paris-based private equity firm specializing in growth-stage investments in deeptech companies across Europe. Founded in 2011, Jolt focuses on supporting technology-rich firms with strong fundamentals, particularly in sectors like photonics, advanced materials, semiconductors, artificial intelligence, and IoT. They typically invest between €10 million and €50 million in businesses that are poised for significant scale, offering both capital and operational expertise to help them expand globally. Jolt Capital stands out by using its proprietary AI platform, Jolt.Ninja, to identify promising investment opportunities. This technology-driven approach allows the firm to discover high-potential companies while avoiding market hype. Their portfolio includes notable companies like Heptagon, NIL Technology, and Verimatrix, all of which leverage cutting-edge technology to address significant market needs. The team at Jolt Capital combines decades of experience in technology, investment, and entrepreneurship, working hands-on with portfolio companies to assist in everything from business strategy to talent acquisition and financial optimization. With a focus on sustainable and responsible investment, Jolt Capital’s mission is to grow European deeptech firms that can transform industries and improve societal outcomes.

Joy Ventures, now rebranded as Corundum Neuroscience, is a venture capital firm originally founded in 2017 and based in Herzliya, Israel. The firm has transitioned its focus to become a neuroscience-focused venture builder and fund. Under its new identity, Corundum Neuroscience aims to drive innovation in neuroscience by investing in and supporting early-stage companies that develop groundbreaking consumer products and technologies rooted in scientific research. The firm specializes in nurturing startups at various stages, from seeding ideas to advancing them through the critical phases of development. Corundum Neuroscience emphasizes creating products that enhance emotional and mental well-being, reflecting its deep commitment to improving human health through innovative technologies. The firm’s strategy includes providing not just financial backing but also extensive resources such as mentorship, strategic guidance, and access to a network of experts in neuroscience and related fields. With its rebranding, Corundum Neuroscience is positioned to become a leader in the neuroscience sector, fostering the development of cutting-edge solutions that address some of the most pressing challenges in mental health and cognitive sciences.

Joyance Partners, established in 2017, is a venture capital firm based in San Francisco, California. The firm focuses on investing in early-stage companies that use science and technology to cultivate joy, aiming to improve the way we live. Joyance Partners has made significant investments in health and consumer sectors, targeting companies from pre-seed to Series A stages across North America, Europe, and Asia. Their notable investments include ClosedLoop, which uses AI to identify at-risk patients and recommend interventions, and Copper Cow Coffee, which delivers a premium Vietnamese coffee experience. Another standout is Cubby, which creates smart beds designed to improve anxiety, sleep, and safety for individuals with cognitive disabilities such as Autism and Epilepsy. Joyance Partners also backs innovative companies in beauty and sustainability, like Conserving Beauty, which focuses on solutions-based skincare, and Electric Era, which works on sustainable energy solutions. The firm has made over 500 investments and boasts more than 200 exits, reflecting a strong track record in nurturing and scaling startups. They support companies that promise to enhance personal health, happiness, and well-being through technological advancements. The leadership team, including Managing Partner Michael Edelhart and Founding Partner William Lohse, leverages their extensive experience to guide their portfolio companies towards growth and success. Joyance Partners continues to be an influential player in the venture capital landscape, dedicated to investing in transformative technologies that bring joy to people's lives​.

The Joint Polish Investment Fund (JPIF) is a venture capital firm based in Warsaw, Poland, established in 2015. The fund primarily focuses on investments in life sciences, targeting early-stage and mid-stage companies, particularly those with clear and near-term value inflection points. JPIF typically holds investments for a period of 3-5 years, aiming to achieve significant growth and value creation during that time. The fund has a specific interest in sectors such as therapeutic devices, monitoring equipment, and personalized medicine, with investments made in companies like Fixnip and DreamJay. JPIF's strategy involves not only providing financial support but also leveraging its team's extensive experience in the life sciences to guide these companies towards successful commercialization. JPIF is led by Kreske Nickelsen, the CEO, along with a team of general partners who bring diverse expertise to the fund's operations. The firm operates under the broader European venture capital landscape, contributing to the growth of innovative life science companies in Central and Eastern Europe.

JPIN Venture Catalysts (JPIN VCATS) is a London-based Euro-Asia focused venture capital firm, angel network, and global advisory founded in 2019. The firm is the international extension of Venture Catalysts (VCATS), India's leading investment network, and sits within the broader Venture Catalysts++ ecosystem — a half-billion-dollar multistage platform comprising 9Unicorns (accelerator VC), Beams Fintech Fund, Elev8 (growth stage), VCATS Angel Growth Fund, and Incubate Hub. JPIN was co-founded by six partners including Dr. Apoorv Sharma, who backed decacorn OYO Hotels at seed stage as well as BharatPe, Beardo, and Supr, alongside Nayan Gala and Gaurav Singh, both UK-based for more than a decade with extensive angel investing track records. The firm invests and syndicates capital from £200K to £20 million, operating sector-agnostically across seed and Series A rounds. The portfolio spans 30 companies across India, the United States, Singapore, and other markets. Notable investments include Zypp Electric (EV rentals, Series C, Gurugram), Chingari (social media), TinyChef, and Expertrons. Exits include Karkinos Healthcare, acquired by Reliance Industries for $43.9 million in December 2024, and Koovers. The most recent investment was BioSapien at seed stage in 2025. JPIN's cross-border strategy is its defining characteristic: the firm actively enables UK and European companies to expand into India while helping Indian companies penetrate UK and European markets. The firm joined the Envestors network for UK deal syndication, and its nine-person team brings a combination of South Asian market expertise and London financial networks to founders seeking to build internationally from an early stage.

JSR Corporation, headquartered in Tokyo, Japan, is a multinational company specializing in digital solutions, life sciences, and elastomers. Founded in 1957, JSR initially focused on synthetic rubbers but has since expanded its operations to become a leading global supplier in various technology-driven markets. One of JSR's major areas of expertise is semiconductor materials, where they produce lithography materials, CMP materials, and packaging solutions essential for semiconductor chip production. The company has also made significant strides in the life sciences sector, providing services and materials for drug discovery, diagnostics, and bioprocessing. They acquired companies like KBI Biopharma and Selexis to strengthen their capabilities in this field. JSR is also heavily involved in advanced semiconductor technologies. They acquired Inpria Corporation, a leader in metal oxide photoresist technology for extreme ultraviolet (EUV) lithography, to bolster their semiconductor materials portfolio. This acquisition aligns with JSR's strategy to enhance their presence in advanced semiconductor manufacturing processes. Moreover, JSR collaborates with Cambridge Quantum Computing (CQC) on quantum computing projects to develop state-of-the-art quantum algorithms. This partnership highlights JSR's commitment to staying at the forefront of technological innovation. Overall, JSR Corporation leverages its extensive R&D capabilities and strategic acquisitions to maintain its leadership in the semiconductor and life sciences industries, continuously driving innovation and value creation for its global customers.

JSW Ventures is an early-stage institutional venture capital fund based in Mumbai, India, founded in 2016 within the JSW Group ecosystem — one of India's largest conglomerates spanning steel, energy, infrastructure, and cement. Fund I launched in 2016 with $10 million, exclusively sponsored by the JSW Family Office (the Jindal family), and delivered 3x returns to investors. Fund II launched in 2020 with $40 million as a multi-LP fund, transitioning the firm to a broader institutional structure, and invested in 13 companies including 8 category leaders. JSW Ventures is currently raising Fund III targeting approximately $54 million to back roughly 15 startups. The firm is SEBI-registered as an Alternative Investment Fund and is led by Managing Partner Sachin Tagra (25-plus years of experience, formerly of Capital18/Network18 and Brand Capital at Times Group), Founding Partner Gaurav Sachdeva, and Partner Vikas Chandak. The firm invests $2 million to $3 million per company at pre-Series A through Series A+ stages across consumer and consumer tech, healthtech, enterprise tech, fintech, sustainability, and agritech. JSW Ventures leads rounds in its portfolio. The most notable investment to date is Purplle, an e-commerce beauty unicorn, which was fully exited in 2023 at 2.7x return. Other portfolio companies include HomeLane (home interiors, which acquired Design Cafe in 2024), HealthPlix (healthtech), Convin.ai ($6.5 million Series A), Aereo (drones), and EcoSoul, the most recent investment made in September 2025. JSW Ventures' investment thesis is anchored in India's demographic dividend, rising consumption, and the transition from unorganized to organized sectors driven by digital penetration. The JSW Group's industrial relationships — across manufacturing, energy, and infrastructure — give portfolio companies access to corporate customers and operational expertise that extend well beyond the reach of a typical financial investor.

Jumpspeed Ventures is the first and only micro-venture capital fund dedicated to investing in early-stage startups originating from the Jerusalem, Israel startup ecosystem. Founded in 2013 by Ben Wiener, a New Yorker who relocated to Jerusalem, the firm now manages $40 million across two funds. Fund II raised $20 million specifically for inception-stage Jerusalem-founded tech startups. Jumpspeed invests $250K to $1 million per company, typically leading or co-leading inception rounds, and backs a small handful of new companies each year. Ben Wiener is the sole General Partner. Jumpspeed has made 37 investments and produced two landmark exits: Zoomin, acquired by Salesforce for $450 million, and Robust Intelligence, acquired by Cisco for $400 million — totaling more than $850 million in acquisition value from a micro-fund, an extraordinary return profile. Other portfolio companies include TensorQ, Raily, Lidwave, and NeuroKaire, which received a Series A investment in December 2024. Investment focus spans AI and machine learning, big data, fintech, healthtech, and enterprise software. Wiener evaluates new investments through the H.E.A.R.T. framework: Hypothesis (a strong market thesis), Enormous Stakes (a large problem or opportunity), Alternatives Grossly Inadequate (current solutions fail), Radically Differentiated Solution (a 10x better paradigm shift), and Team Traits and Skills (the credibility to build and sell). Jumpspeed has been featured by VentureBeat and the Leichtag Foundation as a pioneer in validating Jerusalem as a viable tech ecosystem capable of generating returns alongside the more established Tel Aviv startup scene.

Jumpstart Foundry (JSF) is a Nashville-based pre-seed healthcare innovation fund dedicated to supporting early-stage healthcare startups across the United States. Since its inception, JSF has become one of the most active funds of its kind, making around 35-40 investments annually. The fund primarily focuses on healthcare IT, consumer health products, tech-enabled services, and diagnostic devices, but avoids investing in biotechnology, pharmaceuticals, and life sciences. JSF’s investment model is built around providing strategic capital through a standardized investment structure. Typically, they offer $150,000 via a SAFE (Simple Agreement for Future Equity) note, which helps startups avoid complex negotiations and legal fees. Additionally, companies that receive funding from JSF gain access to the Jumpstart Insight program, which includes strategic resources, leadership training, and networking opportunities designed to support startup growth. Headquartered in Nashville, JSF maintains a broad reach, supporting companies nationwide and seeking founders who demonstrate market validation and early traction. The fund recently launched its ninth publicly-marketed fund under the 506(c) status, allowing it to attract more investors through platforms like AngelList Venture. This shift has opened new opportunities for accredited investors looking to back innovative healthcare solutions. With a commitment to scaling healthcare innovations and lowering barriers to entry, JSF continues to play a vital role in nurturing early-stage companies, providing not just capital, but also the resources and connections needed to drive transformative change in the healthcare industry.

Jumpstart Nova, launched in 2022 with an oversubscribed $55 million fund, is the first venture capital fund exclusively focused on Black-founded and Black-led healthcare companies in the U.S. Based in Nashville and Los Angeles, the fund targets seed and Series A startups in sectors such as health IT, digital health, biotech, diagnostic devices, and tech-enabled healthcare services. Led by founder Marcus Whitney, the fund addresses the long-standing gap in venture capital allocation to Black innovators, with a mission to drive equity in healthcare innovation. Jumpstart Nova’s portfolio includes companies like Alerje, a food allergy management startup, and Cellevolve, a biotech firm focused on cell therapy advancements. The firm is backed by major healthcare institutions including Eli Lilly, HCA Healthcare, and the American Hospital Association, which provide strategic support alongside capital. With a strong focus on fostering both company and leadership development, Jumpstart Nova is more than just a financial investor. The team, which includes partner Kathryne Cooper, works closely with founders, helping them navigate challenges and scale their businesses. Entrepreneurs backed by Jumpstart Nova benefit from their extensive network and industry expertise, ensuring that innovative healthcare solutions from underrepresented groups can thrive.

JumpStart Ventures is a Cleveland, Ohio-based venture capital firm and the investing arm of JumpStart Inc., a nonprofit economic development organization. Founded in 2011, the firm manages more than $200 million across four distinct funds: the Evergreen Fund, Focus Fund, Healthcare Collaboration Fund, and NEXT Fund — providing a continuum of capital from pre-seed through seed and Series A stages. JumpStart Ventures is led by Managing Partner Hardik Desai and has invested in more than 180 high-potential early-stage startups throughout Ohio and the Midwest, delivering top-quartile returns in early-stage B2B SaaS and healthcare. The NEXT Fund III held its first close at $24.55 million toward a $50 million target in March 2025, supported by SSBCI Ohio and 21-plus LPs, with plans to back approximately 15 new startups. JumpStart leads rounds across its portfolio. The firm's most notable exit is CoverMyMeds, an early-stage investment that was acquired by McKesson for more than $1.4 billion — nine years after the initial investment. The firm has recorded more than 30 total exits through acquisitions, including Able Software, Wireless Environment, CardioInsight, Vizzle, and OnShift. Current portfolio companies include Abre (education technology), Centerline Biomedical (medical devices), OnStation (construction tech), Cleveland Diagnostics (cancer diagnostics), Orthobrain (orthodontics AI), and Axuall (healthcare workforce credentialing). Focus sectors span enterprise software, data analytics, biomedical technology, insurtech, fintech, and life sciences. JumpStart Ventures targets companies with greater than $1 billion addressable markets, unique or disruptive solutions, and capital-efficient models. The nonprofit parentage of JumpStart Inc. gives the firm a distinctive economic development mission — supporting Ohio and Midwest entrepreneurs who are often overlooked by coastal investors, while generating the financial returns needed to sustain the broader organization's work.

Jungle Ventures, based in Singapore, is a prominent venture capital firm specializing in early to growth-stage investments across Southeast Asia and India. Established in 2012 by Amit Anand and Anurag Srivastava, the firm has over $1 billion in assets under management and a robust portfolio of companies. Notable investments include Kredivo, a leading digital lending platform in Southeast Asia; Livspace, a platform offering home renovation and interior design services; Moglix, a B2B e-commerce platform for industrial goods; Turtlemint, an insurance technology company facilitating financial advisory services; and Sociolla, a comprehensive beauty and personal care platform. Jungle Ventures focuses on consumer, B2B, and software tech businesses, providing significant capital and strategic support from seed to exit. Their investment strategy includes participating in various funding rounds, often leading or co-leading investments ranging from $500,000 to $20 million, and reserving follow-on capital for further growth. The firm prides itself on deep market knowledge, strong industry relationships, and a collaborative approach, aiding startups in scaling sustainably and reaching global markets.

Juvo Ventures is a mission-driven venture capital firm focused on early-stage, technology-enabled education companies. Founded to empower entrepreneurs who are transforming education, Juvo invests in businesses that improve access, quality, and outcomes across the education-to-work pipeline. The firm’s name, "Juvo," meaning "to help" in Latin, reflects its goal of supporting innovative solutions that enhance learning from early childhood to adulthood. Juvo takes a double-bottom-line approach, seeking both financial returns and meaningful social impact. Its portfolio includes companies like VictoryXR, a leader in immersive learning and "metaversities," Kenzie Academy, which prepares learners for tech careers, and SchooLinks, which helps transform school districts into talent pipelines. Juvo’s investments focus on scaling education technologies that make learning more accessible and adaptable for all. Through partnerships with these innovative companies, Juvo Ventures is actively contributing to better education outcomes, while also addressing critical issues like diversity and inclusion. Their investments align with global goals for sustainable development and offer transformative solutions for both learners and educators alike.

Juxtapose is a New York-based venture studio that takes a unique approach to building and funding companies. Founded in 2015 by Patrick Chun and Jed Cairo, the firm specializes in creating businesses from scratch, focusing on underserved markets where they can make a transformative impact. Juxtapose conducts extensive market research to identify opportunities, then develops the business concept, recruits founding CEOs, and provides both capital and operational support to bring these ideas to life. The firm operates more like a blend of venture capital and private equity, combining the agility of startups with the structured approach of larger buyouts. This strategy has led to successful ventures like Tend, a modern dentistry chain, and Orchard, a real estate platform that simplifies the home buying and selling process. They recently raised $300 million for their second fund to continue scaling their business-building model, aiming for VC-level returns but with the lower risks associated with PE-style management and oversight. Juxtapose’s portfolio spans various industries, including healthcare, real estate, and financial services, with a focus on enhancing consumer experiences. The firm's philosophy emphasizes strategic alignment between investors, management, and other stakeholders to build long-term value. Their approach to innovation and commitment to operational excellence makes them a standout player in the venture studio space.

K Fund is a venture capital firm based in Madrid, Spain, focused on backing tech-driven startups across Southern Europe and Latin America. Founded in 2016, K Fund invests from pre-seed to Series B stages, with check sizes ranging from €100K to €10 million. Their mission is to support visionary, unconventional entrepreneurs who are building scalable, technology-based solutions. The firm’s portfolio includes successful ventures such as Factorial, Exoticca, Voicemod, and Urbanitae, reflecting a diverse range of sectors including SaaS, fintech, travel, and AI. K Fund recently expanded its global footprint by establishing a local presence in São Paulo, Brazil, through their Leadwind fund. This initiative, launched with strategic partners like Telefónica and BBVA, targets deep tech scaleups and aims to bridge the startup ecosystems of Southern Europe and Latin America. Leadwind focuses on sectors like AI, IoT, and blockchain, with the goal of fostering collaboration between these two regions. The fund plans to raise €250 million, making investments starting at €5 million, to help scale these innovative businesses globally. K Fund also emphasizes ESG principles, recently publishing their first impact report, and has committed to promoting sustainability and diversity within their portfolio. Led by a team of seasoned professionals including Miguel Arias and Gustavo S. Carvalhal Ribas, K Fund continues to grow its influence, supporting startups that aim to disrupt traditional markets with cutting-edge technology and scalable business models.

K5 Global is a venture capital firm and incubation studio founded in 2018 by Michael Kives and Bryan Baum. Based in San Francisco, the firm supports founders throughout the entire business lifecycle, from seed stages to IPOs. K5 Global has deployed over $1.1 billion in capital and has made 174 direct investments, resulting in 11 exits. Their portfolio includes high-profile companies such as SpaceX, Uber, Coinbase, Lyft, and The Boring Company. K5 Global focuses on a wide array of industries, including enterprise SaaS, vertical SaaS, fintech, and consumer products. Some notable investments and launched companies include 818 Tequila, Parrot, and The Expert. The firm leverages its extensive network to help innovative companies expand and achieve their growth targets. The management team, led by Michael Kives and Bryan Baum, brings a wealth of experience from various sectors, ensuring robust support for their portfolio companies. K5 Global continues to make significant investments in cutting-edge technologies and groundbreaking startups​.

K5 Ventures is an early-stage technology venture capital and accelerator platform founded in 2010 and headquartered in Irvine, California, with offices in Newport Beach, Orange, Los Angeles, and Beijing. The firm focuses on AI-driven innovations that unlock human creativity, enhance productivity, improve decision-making, and create measurable value for businesses and society. K5 Ventures also operates K5-Launch, the first accelerator in Southern California — a three-to-six-month personalized go-to-market program that provides equity funding up to $25,000 alongside approximately $17,000 in legal, web, and PR services. The firm has made approximately 69 investments across pre-seed through Series A stages and achieved 14 acquisitions across its portfolio. Two unicorns have emerged: Emburse (expense management) and Chainguard (supply chain security). The most recent investment was Era (seed round, August 2024). The most recent exit was Jetty (insurtech, acquired February 2025). Other portfolio companies include Instrumentl (grant discovery), BIOS, CudaSign (acquired), Sphinx, and Farsight. Investment sectors span AI-native companies and vertical AI applications across enterprise SaaS, fintech, healthtech, digital health, medical devices, biotech, food technology, robotics, and predictive analytics. K5 Ventures draws from the Orange County Tech Coast Angels and Investors Circle networks and invests across Southern California, Silicon Valley, and China. The firm's philosophy centers on backing founders building AI-first products in large, underserved markets — combining the structured support of an accelerator program with the capital and long-term partnership of a venture fund. Check sizes are typically small at early stages, making K5 an accessible first institutional partner for companies in the pre-seed and seed ranges.

K50 Ventures, established in 2017 and headquartered in New York, is a venture capital firm dedicated to funding purpose-driven companies at the pre-seed and seed stages. The firm focuses on startups that aim to improve access and affordability in health, finance, and work for the global working class. Notable investments include Mammoth Biosciences, a pioneer in CRISPR technology; Groww, a mobile investing platform in India; and Midi Health, providing specialized healthcare for women over 40. K50 Ventures supports companies that democratize access to financial services, improve healthcare delivery, and empower small businesses and independent workers. Led by founders Ryan Bloomer and Adriel Bercow, K50 Ventures is committed to being the first institutional check and a long-term partner to mission-driven entrepreneurs. They seek founders with a clear vision for creating significant social impact and a solid strategy for execution.

Kae Capital is a prominent early-stage venture capital firm based in Mumbai and Bengaluru, India. Founded in 2012 by Sasha Mirchandani, the firm focuses on investing in pre-seed to pre-series A startups across a variety of sectors, including e-commerce, SaaS, fintech, healthtech, consumer internet, and more. Known for being sector-agnostic, Kae Capital partners with passionate founders to build scalable businesses for both Indian and global markets. Kae Capital has built a strong portfolio, with notable investments in companies like Zetwerk, HealthKart, 1mg, and LoanTap. The firm typically makes seed investments in the range of $1 million, with follow-on rounds in subsequent stages. Their strategy revolves around supporting founders through various growth stages, offering not just financial backing but also operational support, network access, and strategic guidance to help startups find product-market fit and scale effectively. The firm is deeply committed to fostering long-term relationships with founders, with a philosophy centered on being an "all-weather partner." This approach ensures that Kae stays by the side of its portfolio companies during both high-growth phases and challenging times, providing consistent support. With over a decade of experience in early-stage investing, Kae Capital is recognized as a key player in India’s startup ecosystem.

Kairos HQ, founded in 2008 by Ankur Jain, is a venture capital firm based in New York City. Initially launched as The Kairos Society, it aimed to address significant global challenges through innovation. The firm focuses on early to mid-stage investments in healthcare, financial services, and consumer goods sectors, emphasizing affordability and simplicity in everyday life​. Notable investments include Bilt Rewards, a program allowing renters to earn points with rent payments, and Clair, which raised $25 million in its Series A round in July 2023. Other significant investments are Cera Care, a UK-based homecare service, and Alloy Health, a company focused on menopause health. Kairos HQ's strategy leverages its extensive network and expertise in building companies that tackle real-world problems. They manage around $300 million in assets, investing in startups that aim to improve housing affordability and personal health. The leadership team includes Co-CEOs Ankur Jain and Alex Fiance, and they emphasize a hands-on approach to nurturing their portfolio companies, providing strategic guidance and operational support to drive growth and success​.

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.

Kaiser Permanente Ventures (KP Ventures) is a leading venture capital firm dedicated to investing in innovative healthcare solutions. Founded in 1998, KP Ventures has over $500 million in assets under management and focuses on areas such as health information technology, digital health, medical devices, diagnostics, and precision medicine. KP Ventures recently closed its fifth fund at $141 million, which includes contributions from Kaiser Permanente as well as other strategic investors like Tufts Health Plan, Henry Ford Health System, and Highmark Ventures. The firm's investment strategy aims to support companies that address significant unmet needs in the healthcare system, particularly those that align with Kaiser Permanente's mission of providing high-quality, affordable, and accessible care​. Some notable companies in their portfolio include iRhythm, Health Catalyst, and Omada Health. KP Ventures leverages its deep connections with Kaiser Permanente and other healthcare leaders to help its portfolio companies navigate and thrive in the complex healthcare landscape. The team at KP Ventures comprises experienced professionals like Cindy Vanderlinde-Kopper, Amy Belt Raimundo, and co-founders Chris Grant and Chris Stenzel, who bring extensive expertise in healthcare and venture investing.

Kakao Ventures, originally founded as K Cube Ventures in April 2012 and rebranded in March 2017, is the most active seed-stage venture capital firm in South Korea. An independent subsidiary of Kakao Corp., the firm is based in Seoul with offices in Pangyo and manages more than $300 million (over 430 billion KRW) across 11-plus vintage funds with external LP-based structures. The team of 20, including 8 partners, positions itself as a 'co-pilot' to mission-driven founders. Kakao Ventures leads rounds across its portfolio, investing primarily at seed through early Series A stages across four core sectors: deep technology (AI, robotics, semiconductors), IT and services, digital healthcare, and gaming. Kakao Ventures has invested in 280-plus portfolio companies, making roughly 11 new investments annually. In 2024 the firm made 27 investments totaling 20.7 billion KRW, with 19 new companies backed. The portfolio has produced 2 unicorns: Korea Credit Data and Karrot, a community marketplace. IPO exits include Shift UP (KRX listing July 2024, which reached a $2.54 billion market cap as maker of the game Stellar Blade) and Lunit (KRX listing, AI healthcare, $241 million market cap). The firm has recovered 130 billion KRW as first institutional investor across its exits. The most recent investment was Portrai (healthcare technology) in December 2025. Kakao Ventures has established strategic partnerships with Google Cloud, AWS, OpenAI, and Anthropic to provide portfolio companies with AI and cloud infrastructure resources. This access — combined with Kakao Corp.'s dominant position in South Korean digital services — gives portfolio companies a distinctive advantage in reaching both technical resources and consumer distribution within the Korean and broader Asian market.

Kalei Ventures, founded in 2019 and headquartered in Buenos Aires, Argentina, is a venture capital firm focused on early-stage investments in Latin America. The firm aims to support outstanding entrepreneurs building global category leaders within the region. Kalei Ventures invests primarily in sectors such as fintech, e-commerce, logistics, marketplaces, entertainment, education, and B2B SaaS. Notable investments by Kalei Ventures include BrainLogic AI, a company specializing in artificial intelligence, and Moova, a logistics technology firm. The firm also backs startups like AgroForte, which focuses on financial software for agriculture, and Elery, which provides outpatient services technology. These investments highlight Kalei Ventures' dedication to fostering innovation and growth in diverse industries across Latin America. Kalei Ventures' team comprises experienced partners like Leandro Pisaroni Gerbaldo, Pablo Gutierrez Oyhanarte, and Tomás Braun, who leverage their deep industry knowledge and networks to support portfolio companies. The firm is committed to identifying and nurturing high-potential startups, facilitating their expansion and success on a global scale.

Kamet Ventures is a venture builder backed by AXA Insurance with an initial commitment of €100 million, founded in 2016 by Stephane Guinet. Based in Paris at 58 rue de Prony with offices in London and Tel Aviv, Kamet operates a fundamentally different model from traditional venture capital: the firm builds companies from scratch using its own research and solution design framework, then recruits entrepreneurs to run them. The five-person team supports founders from launch across business development, technology, legal, and finance. Focus areas are disruptive innovation in insurtech, healthtech, and mobility. Kamet leads rounds in all companies it creates. The firm has made 39 investments and built a portfolio including Padoa (occupational health SaaS), Akur8 (AI insurance pricing), Birdie (elderly care technology), Fixter (car repair marketplace, UK), Air Doctor (travel health insurance), Anorak (life insurance advice), Brightmile (driver safety and mobility), Ibex (AI pathology), Apricity (fertility health), and Setoo (parametric insurance). Kamet achieved 4 portfolio exits, with the most recent being Sayata (commercial insurance platform, acquired September 2025). An earlier acquisition was Qare (telemedicine, acquired by Kamet in April 2019), and the firm also partnered with Korian (eldercare group) in June 2022. Kamet's venture builder model means the firm identifies market gaps in insurance and health, designs solutions and minimum viable products, then finds founding teams to commercialize them — a cycle that positions Kamet as both investor and architect of each company it backs. This approach, anchored by AXA's deep insurance expertise and distribution relationships, gives Kamet-built companies an unusually direct path to industry validation and enterprise customer access from day one.

Kapor Capital, based in Oakland, California, is renowned for its commitment to investing in early-stage tech startups that drive social impact and economic equity. Their portfolio includes notable startups like Bitly, Life360, and AngelList, reflecting their diverse investment range across sectors such as education, health, finance, and justice. Kapor Capital specifically targets tech-driven ventures that aim to close gaps in access for low-income communities and communities of color. Geographically, Kapor Capital focuses primarily on the United States, with a significant presence in the Bay Area. Their investment strategy emphasizes backing founders who leverage their lived experiences to address real community needs. The firm has a robust investment strategy, often leading funding rounds with average check sizes typically between $500,000 and $1 million. They are known for their active involvement in their portfolio companies, providing extensive support beyond capital, including strategic guidance and fostering a dynamic ecosystem for innovation. The fund prides itself on a rigorous commitment to diversity, with a significant portion of their investments going to companies with underrepresented and women founders. In 2023 alone, they deployed $10.7 million across 19 companies, demonstrating their active investment approach. Founders can approach Kapor Capital through their Platform team, which curates events and builds networks to support portfolio companies. Key team members include Mitch Kapor and Freada Kapor Klein, who bring decades of experience in tech and social impact investing. Their leadership has been pivotal in shaping the firm’s mission-driven approach. With a deep commitment to creating a fairer society, Kapor Capital continues to lead the way in impact investing.

Karista is an early-stage venture capital firm based in Paris, specializing in Health, Digital, Technology, and NewSpace sectors. Founded in 2001, the firm has backed over 100 companies, providing more than just financial support. Karista is known for its hands-on approach, helping startups with team structuring, business development, and strategic guidance. Notable investments include Exotrail, a company developing agile space mobility solutions, and Incepto, which raised €27M for its digital health platform. Karista typically invests between €500k and €2.5M in seed and Series A rounds, with follow-on investments up to €6M. They often take board seats to offer deep involvement in the companies they support. Karista's strategy emphasizes early investment in innovative projects with strong value propositions. They co-create with founders, ensuring alignment in vision and goals. The firm manages several funds, including the Paris Region Venture Fund and the SpaceTech fund, focusing on companies ready to impact their markets and improve user lives.

Karma Ventures is an early-stage venture capital firm based in Tallinn, Estonia, specializing in late seed and Series A investments in Europe's deep-tech software startups. Founded in 2016 by Margus Uudam and Tommi Uhari, the firm focuses on companies with strong technological innovation, initial commercial traction, and global ambitions. Notable investments by Karma Ventures include Wirepas, an industrial IoT company; Tuum (formerly Modularbank), a fintech platform; Lucinity, an AI-driven anti-money laundering platform; and BforeAI, a network management software company. These investments highlight the firm's commitment to backing startups with unique technologies and significant market potential. Karma Ventures typically invests up to EUR 5 million per company and continues to support them through follow-on investments in later rounds. The firm's portfolio also includes companies like Sonarworks, MeetFrank, and Xolo, further showcasing its focus on diverse technological innovations. The firm operates with a hands-on approach, providing strategic, commercial, and technical support to help startups navigate their growth paths. Karma Ventures leverages the expertise of its partners and advisors, including notable figures like Ahti Heinla, co-founder of Skype and Starship Technologies, and Sergei Anikin, former CTO of Pipedrive.

Karman Ventures, formerly known as Moving Capital, is a venture capital firm co-founded by early Uber employees. Based in the United States, Karman primarily focuses on investing in innovative, tech-driven startups across various sectors, including transportation, aerospace, fintech, and consumer services. The firm has built a robust portfolio featuring companies like Whisper Aero, SkyFi, and JOKR, which have shown significant promise in their respective industries. They also have a record of supporting unicorns such as Unit, an open banking solution, and Omio, a platform for booking transportation services globally. Karman Ventures’ investment strategy emphasizes supporting early to growth-stage companies, with an average round size of $31 million. The firm tends to follow rather than lead investment rounds, collaborating with other prominent investors. Despite this, Karman’s network and strategic guidance are pivotal for scaling its portfolio companies, enabling them to grow rapidly within their markets. Karman’s global reach is evident through its diverse portfolio, which includes investments across the US, Europe, and parts of Asia. Karman continues to back companies that demonstrate potential for market disruption and scalability, providing them not only with capital but also strategic expertise drawn from the experience of its founding team and partners. This approach positions Karman Ventures as a dynamic player in the venture capital landscape, blending its roots in tech with a forward-looking investment ethos.

Kaszek is the largest venture capital firm in Latin America, founded in 2011 by Hernan Kazah and Nicolas Szekasy — MercadoLibre co-founder/COO and former CFO, respectively. Based in Sao Paulo with operations across the region, the firm manages approximately $2.9 billion across six early-stage funds and three opportunity and growth funds. Fund history spans from KV-I ($95 million, 2011) and KV-II ($135 million, 2014) through KV-VI plus Opportunity III ($975 million, 2023). The team includes partners Nicolas Berman (former MercadoLibre VP with 20-plus years of operational experience), Santiago Fossatti (with the firm since inception), and Andy Young. Kaszek leads rounds across its portfolio and invests in technology-based companies targeting Latin America as their primary market, at seed through Series A and growth stages with checks ranging from the millions to $10-50 million. Kaszek has invested in 130 companies over 15 years, backing roughly 9 new companies annually. The portfolio includes some of Latin America's most iconic technology companies: Nubank (NYSE-listed, the largest digital bank in the region), Kavak (used car marketplace), QuintoAndar (proptech), Creditas (fintech), WellHub/Gympass (corporate wellness), Loggi (logistics), Bitso (crypto exchange), Clara (corporate cards), Nuvemshop (e-commerce platform), Notco (food tech), and Konfio (SME lending). Twenty-four portfolio companies have been acquired. The latest investment was Azos (life insurance) in March 2026, and the most recent exit was Gringo, acquired by Corpay in February 2025. Kaszek's founders-turned-investors thesis — applying direct operational experience at one of Latin America's most successful internet companies — shapes how the firm supports founders through the scaling challenges particular to the region: regulatory complexity, fragmented markets, and capital cycles that differ markedly from those in North America or Europe.